This study also revealed a stepwise decrease in the frequency of abnormal type 53BP1 expression with ML progression [FL1 > FL2 > FL3A > DLBCL (germinal center type)]. The gene discussed is TP53BP1; the disease is diffuse large B-cell lymphoma.